Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 644

1.

Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.

Ibrahim YH, Byron SA, Cui X, Lee AV, Yee D.

Mol Cancer Res. 2008 Sep;6(9):1491-8. doi: 10.1158/1541-7786.MCR-07-2173.

2.
6.
8.
9.
10.
11.
13.

Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.

del Rincón SV, Rousseau C, Samanta R, Miller WH Jr.

Oncogene. 2003 May 29;22(22):3353-60.

PMID:
12776186
15.

Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.

Beery R, Haimsohn M, Wertheim N, Hemi R, Nir U, Karasik A, Kanety H, Geier A.

Endocrinology. 2001 Jul;142(7):3098-107.

PMID:
11416032
16.

Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D.

Mol Endocrinol. 1999 May;13(5):787-96.

PMID:
10319328
17.

Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.

Sugita H, Kaneki M, Furuhashi S, Hirota M, Takamori H, Baba H.

Mol Cancer Res. 2010 Aug;8(8):1152-63. doi: 10.1158/1541-7786.MCR-09-0472.

19.
20.

Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.

Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ.

Diabetes. 2002 Apr;51(4):966-76.

Items per page

Supplemental Content

Support Center